Diabetic patients treated for unprotected left main coronary artery disease with drug eluting stents: a 3-year clinical outcome study. The diabetes and drug eluting stent for LeFT main registry (D-DELFT).

@article{Meliga2008DiabeticPT,
  title={Diabetic patients treated for unprotected left main coronary artery disease with drug eluting stents: a 3-year clinical outcome study. The diabetes and drug eluting stent for LeFT main registry (D-DELFT).},
  author={Emanuele Meliga and H. M. Garcia-Garcia and Marco Valgimigli and Alaide Chieffo and Giuseppe G. L. Biondi-Zoccai and Andrew O. Maree and Nieves Gonzalo and St{\'e}phane Cook and ignacio Cruz-Gonzalez and Sebastiano Marra and Stefano de Servi and Igor F. Palacios and Stephan Windecker and Ron Theodoor van Domburg and Antonio Colombo and Imad Sheiban and Patrick Washington Serruys},
  journal={EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology},
  year={2008},
  volume={4 1},
  pages={77-83}
}
AIMS Diabetes mellitus (DM) plays an important role in the development of coronary artery disease. Although previous studies have associated drug-eluting stent (DES) implantation in diabetic patients with favourable clinical and angiographic outcomes, the very long-term efficacy of these devices in diabetic patients undergoing PCI for significant unprotected left main coronary artery (ULMCA) disease has not been established yet. METHODS AND RESULTS Consecutive diabetic patients (n=100), who… CONTINUE READING

Similar Papers

Loading similar papers…